BLOG

Featured

Press Release Biomanufacturing

Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD

San Diego, CA – January 8, 2025 – National Resilience, Inc. (Resilience), a technology-driven biomanufacturing leader dedicated to broadening access...

Read on

Biomanufacturing Drug Product

Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space

Manufacturing capabilities need innovation proportional to those in therapeutics discovery. Choosing a CDMO partner with the technologies and...

Read on

Latest

All News Webinars Videos Articles

Technology Artificial Intelligence

Developing New Medicines Through Artificial Intelligence

On September 30, 2012, a computer program named “AlexNet” won an international competition and ushered in a new age of artificial intelligence (AI)....

Read on

	
		OSZAR »

BLOG

Featured

Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD

Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space

Latest

Developing New Medicines Through Artificial Intelligence

NATIONAL RESILIENCE